State highlights: Calif. gov. signs bills on prescription drug abuse; Texas groups sue over parts of abortion law; Calif.'s drug Medi-Cal program probed

A selection of health policy stories from California and Texas.

Los Angeles Times: Gov. Brown Signs 2 Of 3 Bills Fighting Prescription Drug Abuse 
Gov. Jerry Brown signed two bills Friday aimed at curbing prescription drug abuse but vetoed a third that could have helped the state's medical board identify reckless doctors whose patients died on pills they prescribed (Glover and Girion, 9/27).

The New York Times: Rights Groups And Clinics Sue Texas Over Provisions In Its New Abortion Law
National women's rights groups and Texas abortion clinics filed suit on Friday in federal court in Texas, seeking to block provisions of a new state law that they said would have "dramatic and draconian effects" on women's access to the procedure (Eckholm, 9/27).

California Healthline: DHCS Director Apologizes At Hearing Examining Medi-Cal Drug Program Fraud
Department of Health Care Services director Toby Douglas apologized for "lapses in state oversight" of a Medi-Cal drug abuse treatment program at a hearing yesterday in Sacramento. … Yesterday's joint legislative oversight hearing was convened to address allegations of fraud and Medi-Cal system abuse within the Drug Medi-Cal program, which is overseen by DHCS. Reports by the Center for Investigative Reporting and CNN said rampant and persistent fraud went relatively untouched by state oversight (Gorn, 9/27).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
How does prenatal cannabis use affect neonatal outcomes?